Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis.
作者信息
Johnson Daniel E
机构信息
Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh, 5117 Centre Avenue, Pittsburgh, PA 15213-1863, USA.
出版信息
Adv Enzyme Regul. 2008;48:98-112. doi: 10.1016/j.advenzreg.2007.11.002. Epub 2007 Nov 19.
Abstract
摘要
相似文献
1
Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis.
Adv Enzyme Regul. 2008;48:98-112. doi: 10.1016/j.advenzreg.2007.11.002. Epub 2007 Nov 19.
2
MEK/ERK dependent activation of STAT1 mediates dasatinib-induced differentiation of acute myeloid leukemia.
PLoS One. 2013 Jun 25;8(6):e66915. doi: 10.1371/journal.pone.0066915. Print 2013.
3
Oncoprotein Cot1 represses kinase suppressors of Ras1/2 and 1,25-dihydroxyvitamin D3-induced differentiation of human acute myeloid leukemia cells.
J Cell Physiol. 2011 May;226(5):1232-40. doi: 10.1002/jcp.22449.
4
BAALC potentiates oncogenic ERK pathway through interactions with MEKK1 and KLF4.
Leukemia. 2015 Nov;29(11):2248-56. doi: 10.1038/leu.2015.137. Epub 2015 Jun 8.
5
Dasatinib synergizes with ATRA to trigger granulocytic differentiation in ATRA resistant acute promyelocytic leukemia cell lines via Lyn inhibition-mediated activation of RAF-1/MEK/ERK.
Food Chem Toxicol. 2018 Sep;119:464-478. doi: 10.1016/j.fct.2017.10.053. Epub 2017 Oct 31.
6
Cytokine-induced myeloid differentiation is dependent on activation of the MEK/ERK pathway.
Leuk Res. 2005 Nov;29(11):1293-306. doi: 10.1016/j.leukres.2005.03.016.
7
Activation of mitogen-activated protein kinase kinase (MEK)/extracellular signal regulated kinase (ERK) signaling pathway is involved in myeloid lineage commitment.
Blood. 2007 Sep 1;110(5):1420-8. doi: 10.1182/blood-2007-02-071761. Epub 2007 May 29.
8
Helicobacter pylori CagA induces ornithine decarboxylase upregulation via Src/MEK/ERK/c-Myc pathway: implication for progression of gastric diseases.
Exp Biol Med (Maywood). 2012 Apr;237(4):435-41. doi: 10.1258/ebm.2011.011199. Epub 2012 Mar 22.
9
MEK-ERK signaling plays diverse roles in the regulation of facial chondrogenesis.
Exp Cell Res. 2006 Apr 15;312(7):1079-92. doi: 10.1016/j.yexcr.2005.12.028. Epub 2006 Feb 2.
10
Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and src-dependent tyrosine phosphorylation of RSK2 at Tyr-529.
J Biol Chem. 2008 Feb 22;283(8):4652-7. doi: 10.1074/jbc.M709673200. Epub 2007 Dec 21.
引用本文的文献
1
Molecular Mechanisms Underlying Amyloid Beta Peptide Mediated Upregulation of Vascular Cell Adhesion Molecule-1 in Alzheimer Disease.
J Pharmacol Exp Ther. 2024 Nov 19;391(3):430-440. doi: 10.1124/jpet.124.002280.
2
A synthetic bioactive peptide of the C-terminal fragment of adhesion protein Fibulin7 attenuates the inflammatory functions of innate immune cells in LPS-induced systemic inflammation.
Inflamm Res. 2024 Aug;73(8):1333-1348. doi: 10.1007/s00011-024-01903-7. Epub 2024 Jun 5.
3
Rhein Induces Oral Cancer Cell Apoptosis and ROS via Suppresse AKT/mTOR Signaling Pathway In Vitro and In Vivo.
Int J Mol Sci. 2023 May 9;24(10):8507. doi: 10.3390/ijms24108507.
4
Inhibition of a signaling modality within the gp130 receptor enhances tissue regeneration and mitigates osteoarthritis.
Sci Transl Med. 2023 Mar 22;15(688):eabq2395. doi: 10.1126/scitranslmed.abq2395.
5
Cytomegalovirus US28 regulates cellular EphA2 to maintain viral latency.
Sci Adv. 2022 Oct 28;8(43):eadd1168. doi: 10.1126/sciadv.add1168. Epub 2022 Oct 26.
6
Anti-leukemic principle(s) from seeds induce differentiation of HL-60 cells through ERK/MAPK signalling pathway.
Cytotechnology. 2022 Oct;74(5):591-611. doi: 10.1007/s10616-022-00547-x. Epub 2022 Sep 12.
7
Evidence of off-target effects of bosutinib that promote retinoic acid-induced differentiation of non-APL AML cells.
Cell Cycle. 2021 Dec;20(24):2638-2651. doi: 10.1080/15384101.2021.2005275. Epub 2021 Nov 26.
8
Activator protein-1 transactivation of the major immediate early locus is a determinant of cytomegalovirus reactivation from latency.
Proc Natl Acad Sci U S A. 2020 Aug 25;117(34):20860-20867. doi: 10.1073/pnas.2009420117. Epub 2020 Aug 11.
9
Imidazo[1,2-]pyrazole-7-Carboxamide Derivative Induces Differentiation-Coupled Apoptosis of Immature Myeloid Cells Such as Acute Myeloid Leukemia and Myeloid-Derived Suppressor Cells.
Int J Mol Sci. 2020 Jul 20;21(14):5135. doi: 10.3390/ijms21145135.
10
Inhibition of non-receptor tyrosine kinase Src induces phosphoserine 256-independent aquaporin-2 membrane accumulation.
J Physiol. 2019 Mar;597(6):1627-1642. doi: 10.1113/JP277024. Epub 2018 Dec 21.
本文引用的文献
1
Signal transduction pathways that contribute to myeloid differentiation.
Leukemia. 2007 Jul;21(7):1363-77. doi: 10.1038/sj.leu.2404690. Epub 2007 Apr 19.
2
Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistance.
Adv Enzyme Regul. 2007;47:64-103. doi: 10.1016/j.advenzreg.2006.12.013. Epub 2007 Mar 26.
3
Important therapeutic targets in chronic myelogenous leukemia.
Clin Cancer Res. 2007 Feb 15;13(4):1089-97. doi: 10.1158/1078-0432.CCR-06-2147.
4
Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase.
Blood. 2007 May 15;109(10):4143-50. doi: 10.1182/blood-2006-09-046839. Epub 2007 Jan 30.
5
Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD.
Leukemia. 2007 Mar;21(3):403-10. doi: 10.1038/sj.leu.2404547. Epub 2007 Jan 18.
6
Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis.
Blood. 2007 Apr 15;109(8):3207-13. doi: 10.1182/blood-2006-09-046888. Epub 2006 Dec 21.
7
Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy.
Blood. 2007 Mar 15;109(6):2303-9. doi: 10.1182/blood-2006-09-047266. Epub 2006 Nov 30.
8
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.
Biochim Biophys Acta. 2007 Aug;1773(8):1263-84. doi: 10.1016/j.bbamcr.2006.10.001. Epub 2006 Oct 7.
9
FLT3 mutations: biology and treatment.
Hematology Am Soc Hematol Educ Program. 2006:178-84. doi: 10.1182/asheducation-2006.1.178.
10
MEK blockade converts AML differentiating response to retinoids into extensive apoptosis.
Blood. 2007 Mar 1;109(5):2121-9. doi: 10.1182/blood-2006-05-024679. Epub 2006 Oct 31.
Zotero 插件